Human KCNK9 ELISA Kit (V2LY-0626-LY1931)

Cheng, Y., Tang, Y., Tan, Y., Li, J., & Zhang, X. (2023). KCNK9 mediates the inhibitory effects of genistein on hepatic metastasis from colon cancer. Clinics, 78, 100141.

Loftus, D., Bae, B., Whilden, C. M., & Whipple, A. J. (2023). Allelic chromatin structure primes imprinted expression of Kcnk9 during neurogenesis. bioRxiv, 2023-06.

Villavisanis, D. F., Blum, J. D., & Taylor, J. A. (2023). Birk-Barel Intellectual Disability Dimorphism and KCNK9 Imprinting Syndrome: Craniofacial Surgery Considerations for an Exceedingly Rare Syndrome. Journal of Craniofacial Surgery, 34(1), e25-e28.

Rojas, C. R., Cercy, J., Perillous, S., Gonthier-Guéret, C., Montibus, B., Maupetit-Méhouas, S., ... & Court, F. (2023). Biallelic non-productive enhancer-promoter interaction precedes imprinted expression of Kcnk9 during mouse neural commitment. bioRxiv, 2023-09.

Chu, L. H., Liao, C. C., Liew, P. L., Chen, C. W., Su, P. H., Wen, K. C., ... & Chen, L. Y. (2022). Epigenomic analysis reveals the KCNK9 potassium channel as a potential therapeutic target for adenomyosis. International journal of molecular sciences, 23(11), 5973.

Cousin, M. A., Veale, E. L., Dsouza, N. R., Tripathi, S., Holden, R. G., Arelin, M., ... & Klee, E. W. (2022). Gain and loss of TASK3 channel function and its regulation by novel variation cause KCNK9 imprinting syndrome. Genome medicine, 14(1), 62.

Pfeuffer, S., Müntefering, T., Rolfes, L., Straeten, F. A., Eichler, S., Gruchot, J., ... & Meuth, S. G. (2022). Deficiency of the Two-Pore Potassium Channel KCNK9 Impairs Intestinal Epithelial Cell Survival and Aggravates Dextran Sodium Sulfate-Induced Colitis. Cellular and Molecular Gastroenterology and Hepatology, 14(6), 1199-1211.

Skaar, D. A., Dietze, E. C., Alva-Ornelas, J. A., Ann, D., Schones, D. E., Hyslop, T., ... & Seewaldt, V. L. (2021). Epigenetic Dysregulation of KCNK9 Imprinting and Triple-Negative Breast Cancer. Cancers, 13(23), 6031.

Šedivá, M., Laššuthová, P., Zámečník, J., Sedláčková, L., Seeman, P., & Haberlová, J. (2020). Novel variant in the KCNK9 gene in a girl with Birk Barel syndrome. European Journal of Medical Genetics, 63(1), 103619.

Cunningham, K. P., MacIntyre, D. E., Mathie, A., & Veale, E. L. (2020). Effects of the ventilatory stimulant, doxapram on human TASK‐3 (KCNK9, K2P9. 1) channels and TASK‐1 (KCNK3, K2P3. 1) channels. Acta physiologica, 228(2), e13361.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols